Free Trial

SLB (SLB) Financials

SLB logo
$55.64 +0.26 (+0.47%)
As of 10:06 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for SLB

Annual Income Statements for SLB

This table shows SLB's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
2,072 -1,687 -1,505 2,138 -10,137 -10,518 1,881 3,441 4,203 4,461 3,374
Consolidated Net Income / (Loss)
2,135 -1,627 -1,513 2,177 -10,107 -10,486 1,928 3,492 4,275 4,579 3,451
Net Income / (Loss) Continuing Operations
2,135 -1,627 -1,513 2,177 -10,107 -10,486 1,928 3,492 4,275 4,579 3,451
Total Pre-Tax Income
2,881 -1,905 -1,183 2,624 -10,418 -11,298 2,374 4,271 5,282 5,672 4,291
Total Operating Income
2,991 -1,535 2,370 2,835 -10,142 -11,002 2,765 4,151 5,443 5,804 4,368
Total Gross Profit
7,154 3,401 3,897 4,337 4,197 2,601 3,658 5,161 6,563 7,460 6,507
Total Revenue
35,475 27,810 30,440 32,815 32,917 23,601 22,929 28,091 33,135 36,289 35,708
Operating Revenue
35,475 27,810 30,440 32,815 32,917 23,601 22,929 28,091 33,135 36,289 35,708
Total Cost of Revenue
28,321 24,409 26,543 28,478 28,720 21,000 19,271 22,930 26,572 28,829 29,201
Operating Cost of Revenue
28,321 24,409 26,543 28,478 28,720 21,000 19,271 22,930 26,572 28,829 29,201
Total Operating Expenses
4,163 4,936 1,527 1,502 14,339 13,603 893 1,010 1,120 1,656 2,139
Selling, General & Admin Expense
494 403 432 444 474 365 339 376 364 385 340
Research & Development Expense
1,094 1,012 787 702 717 580 554 634 711 749 709
Impairment Charge
2,575 3,172 - 356 13,148 12,658 - - 0.00 162 331
Restructuring Charge
0.00 349 308 - - - 0.00 0.00 45 360 759
Total Other Income / (Expense), net
-110 -370 -3,553 -211 -276 -296 -391 120 -161 -132 -77
Interest Expense
346 570 566 575 609 563 539 490 503 512 558
Interest & Investment Income
236 200 224 149 86 267 148 610 342 380 481
Income Tax Expense
746 -278 330 447 -311 -812 446 779 1,007 1,093 840
Net Income / (Loss) Attributable to Noncontrolling Interest
63 60 -8.00 39 30 32 47 51 72 118 77
Basic Earnings per Share
$1.63 ($1.24) ($1.08) $1.54 ($7.32) ($7.57) $1.34 $2.43 $2.95 $3.14 $2.38
Weighted Average Basic Shares Outstanding
1.27B 1.36B 1.39B 1.39B 1.39B 1.39B 1.40B 1.42B 1.43B 1.42B 1.42B
Diluted Earnings per Share
$1.63 ($1.24) ($1.08) $1.53 ($7.32) ($7.57) $1.32 $2.39 $2.91 $3.11 $2.35
Weighted Average Diluted Shares Outstanding
1.28B 1.36B 1.39B 1.39B 1.39B 1.39B 1.43B 1.44B 1.44B 1.44B 1.44B
Weighted Average Basic & Diluted Shares Outstanding
1.27B 1.36B 1.39B 1.39B 1.38B 1.39B 1.40B 1.42B 1.43B 1.40B 1.50B

Quarterly Income Statements for SLB

This table shows SLB's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
1,123 1,113 1,068 1,112 1,186 1,095 797 1,014 739 824 752
Consolidated Net Income / (Loss)
1,136 1,148 1,098 1,145 1,218 1,118 829 1,048 774 800 761
Net Income / (Loss) Continuing Operations
1,136 1,148 1,098 1,145 1,218 1,118 829 1,048 774 800 761
Total Pre-Tax Income
1,395 1,433 1,357 1,421 1,507 1,387 1,063 1,285 1,000 943 956
Total Operating Income
1,451 1,468 1,386 1,468 1,547 1,403 1,132 1,175 1,064 997 1,029
Total Gross Profit
1,718 1,797 1,700 1,877 1,922 1,961 1,606 1,612 1,558 1,731 1,331
Total Revenue
8,310 8,990 8,707 9,139 9,159 9,284 8,490 8,546 8,928 9,744 8,721
Operating Revenue
8,310 8,990 8,707 9,139 9,159 9,284 8,490 8,546 8,928 9,744 8,721
Total Cost of Revenue
6,592 7,193 7,007 7,262 7,237 7,323 6,884 6,934 7,370 8,013 7,390
Operating Cost of Revenue
6,592 7,193 7,007 7,262 7,237 7,323 6,884 6,934 7,370 8,013 7,390
Total Operating Expenses
267 329 314 409 375 558 474 437 494 734 302
Selling, General & Admin Expense
81 96 121 94 90 80 96 87 72 85 97
Research & Development Expense
186 188 182 188 187 192 172 180 170 187 164
Restructuring Charge
0.00 45 11 127 98 286 206 170 252 131 41
Total Other Income / (Expense), net
-56 -35 -29 -47 -40 -16 -69 110 -64 -54 -73
Interest Expense
129 130 113 132 136 131 147 142 142 127 116
Interest & Investment Income
73 95 84 85 96 115 78 252 78 73 43
Income Tax Expense
259 285 259 276 289 269 234 237 226 143 195
Net Income / (Loss) Attributable to Noncontrolling Interest
13 35 30 33 32 23 32 34 35 -24 9.00
Basic Earnings per Share
$0.79 $0.78 $0.75 $0.78 $0.84 $0.77 $0.58 $0.75 $0.50 $0.55 $0.50
Weighted Average Basic Shares Outstanding
1.42B 1.43B 1.43B 1.43B 1.42B 1.42B 1.37B 1.35B 1.47B 1.42B 1.50B
Diluted Earnings per Share
$0.78 $0.76 $0.74 $0.77 $0.83 $0.77 $0.58 $0.74 $0.50 $0.53 $0.50
Weighted Average Diluted Shares Outstanding
1.44B 1.44B 1.45B 1.44B 1.43B 1.44B 1.38B 1.37B 1.49B 1.44B 1.52B
Weighted Average Basic & Diluted Shares Outstanding
1.42B 1.43B 1.43B 1.42B 1.41B 1.40B 1.36B 1.35B 1.49B 1.50B 1.50B

Annual Cash Flow Statements for SLB

This table details how cash moves in and out of SLB's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-306 209 -1,149 -347 -298 -282 908 -50 1,342 685 -565
Net Cash From Operating Activities
8,572 6,261 5,663 5,713 5,431 2,944 4,651 3,720 6,637 6,602 6,489
Net Cash From Continuing Operating Activities
8,805 6,261 5,663 5,713 5,431 2,944 4,687 3,720 6,626 6,559 6,489
Net Income / (Loss) Continuing Operations
2,135 -1,627 -1,513 2,177 -10,107 -10,486 1,928 3,492 4,275 4,579 3,451
Consolidated Net Income / (Loss)
2,135 -1,627 -1,513 2,177 -10,107 -10,486 1,928 3,492 4,275 4,579 3,451
Depreciation Expense
4,078 4,094 3,837 3,556 3,589 2,566 2,120 2,147 2,312 2,519 2,643
Amortization Expense
- - - - - - - - - - 166
Non-Cash Adjustments To Reconcile Net Income
2,868 4,040 3,918 355 13,312 12,884 238 -130 125 436 455
Changes in Operating Assets and Liabilities, net
-276 -246 -579 -375 -1,363 -2,020 401 -1,789 -86 -975 -226
Net Cash From Investing Activities
-10,252 -624 -1,779 -1,040 -2,011 -2,353 -919 -1,388 -2,783 -3,145 -1,412
Net Cash From Continuing Investing Activities
-10,252 -624 -1,779 -1,040 -2,011 -2,353 -919 -1,388 -2,783 -3,145 -1,412
Purchase of Property, Plant & Equipment
-2,896 -2,685 -2,383 -2,260 -1,955 -1,217 -1,180 -2,205 -1,939 -1,931 -1,694
Acquisitions
-443 -2,398 -847 -292 -23 -33 -103 -155 -395 -751 40
Purchase of Investments
-953 -1,031 -1,609 -981 -781 -303 -474 -121 -575 -690 -685
Divestitures
- 0.00 - 579 586 434 0.00 - 0.00 0.00 338
Sale and/or Maturity of Investments
-5,848 5,544 3,277 1,943 317 -1,141 896 1,186 234 120 194
Other Investing Activities, net
-112 -54 -217 -29 -155 -93 -58 -93 -108 107 395
Net Cash From Financing Activities
1,374 -5,428 -5,033 -5,020 -3,718 -873 -2,824 -2,382 -2,512 -2,772 -5,642
Net Cash From Continuing Financing Activities
1,374 -5,428 -5,033 -5,020 -3,718 -873 -2,824 -2,382 -2,512 -2,772 -5,642
Repayment of Debt
-4,038 -6,058 -3,983 -3,009 -4,894 -5,068 -2,272 -1,664 -1,607 -1,135 -1,794
Repurchase of Common Equity
-2,182 -778 -969 -400 -278 -26 0.00 0.00 -694 -1,737 -2,414
Payment of Dividends
-2,419 -2,647 -2,778 -2,770 -2,769 -1,734 -699 -848 -1,317 -1,533 -1,602
Issuance of Debt
9,565 3,640 2,400 898 4,004 5,837 34 0.00 994 1,475 0.00
Issuance of Common Equity
296 231 212 227 196 146 137 142 191 219 222
Other Financing Activities, net
152 184 85 34 23 -28 -24 -12 -79 -61 -54

Quarterly Cash Flow Statements for SLB

This table details how cash moves in and out of SLB's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
562 493 -91 164 130 482 -650 277 -206 14 -214
Net Cash From Operating Activities
1,677 3,022 327 1,436 2,449 2,390 660 1,142 1,682 3,005 487
Net Cash From Continuing Operating Activities
1,677 3,022 327 1,436 2,449 2,390 660 1,142 1,682 3,005 487
Net Income / (Loss) Continuing Operations
1,137 1,148 1,098 1,145 1,218 1,118 829 1,048 774 800 761
Consolidated Net Income / (Loss)
1,137 1,148 1,098 1,145 1,218 1,118 829 1,048 774 800 761
Depreciation Expense
579 609 600 631 640 648 640 633 638 732 685
Non-Cash Adjustments To Reconcile Net Income
17 209 84 243 162 325 81 -40 129 285 104
Changes in Operating Assets and Liabilities, net
-56 1,056 -1,455 -583 429 299 -890 -499 141 1,022 -1,063
Net Cash From Investing Activities
-733 -520 -151 -1,493 -1,024 -477 -432 246 44 -1,270 33
Net Cash From Continuing Investing Activities
-733 -520 -151 -1,493 -1,024 -477 -432 246 44 -1,270 33
Purchase of Property, Plant & Equipment
-502 -980 -399 -525 -510 -951 -398 -371 -409 -516 -343
Acquisitions
-18 -115 -56 -478 -47 -199 -88 -42 297 -127 -121
Purchase of Investments
-319 504 -173 -135 -538 555 -108 -165 -131 -206 -103
Sale and/or Maturity of Investments
115 6.00 424 -343 45 60 177 494 -18 -522 600
Other Investing Activities, net
-9.00 65 53 -12 26 58 -15 14 283 101 0.00
Net Cash From Financing Activities
-382 -2,009 -267 221 -1,295 -1,431 -878 -1,111 -1,932 -1,721 -734
Net Cash From Continuing Financing Activities
-382 -2,009 -267 221 -1,295 -1,431 -878 -1,111 -1,932 -1,721 -734
Repayment of Debt
-9.00 -1,553 -22 -429 -143 -541 -57 2.00 -1,105 -634 -758
Repurchase of Common Equity
-151 -100 -270 -465 -501 -501 -2,300 - -114 - -451
Payment of Dividends
-356 -356 -357 -394 -393 -389 -386 -387 -403 -426 -426
Issuance of Debt
- 2.00 345 1,504 -374 - 1,805 -724 -421 -660 782
Issuance of Common Equity
105 - 100 - 119 - 105 - 117 - 104
Other Financing Activities, net
29 -2.00 -63 5.00 -3.00 - -45 -2.00 -6.00 -1.00 15

Annual Balance Sheets for SLB

This table presents SLB's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
68,005 77,956 71,987 70,507 56,312 42,434 41,511 43,135 47,957 48,935 54,868
Total Current Assets
26,912 23,927 18,497 15,731 15,530 12,919 12,654 15,003 17,718 18,570 19,513
Cash & Equivalents
2,793 2,929 1,799 1,433 1,137 844 1,757 1,655 2,900 3,544 3,036
Short-Term Investments
10,241 6,328 3,290 1,344 1,030 2,162 1,382 1,239 1,089 1,125 1,176
Accounts Receivable
8,780 9,387 8,084 7,881 7,747 5,247 5,315 6,766 7,812 8,011 8,689
Inventories, net
3,756 4,225 4,046 4,010 4,130 3,354 3,272 3,999 4,387 4,375 5,032
Other Current Assets
1,134 1,058 1,278 1,063 1,486 1,312 928 1,344 1,530 1,515 1,580
Plant, Property, & Equipment, net
13,415 12,821 11,576 11,679 9,270 6,826 6,429 6,607 7,240 7,359 7,894
Total Noncurrent Assets
27,678 41,208 41,914 43,097 31,512 22,689 22,428 21,525 22,999 23,006 27,461
Long-Term Investments
3,729 1,481 1,519 1,538 1,565 2,061 2,044 1,581 1,624 1,635 1,783
Goodwill
15,605 24,990 25,118 24,931 16,042 12,980 12,990 12,982 14,084 14,593 16,794
Intangible Assets
4,569 9,855 9,354 8,727 7,089 3,455 3,211 2,992 3,239 3,012 4,988
Other Noncurrent Operating Assets
3,775 4,882 5,923 7,901 6,816 4,193 4,183 3,970 4,052 3,766 3,896
Total Liabilities & Shareholders' Equity
68,005 77,956 71,987 70,507 56,312 42,434 41,511 43,135 47,957 48,935 54,868
Total Liabilities
32,100 36,427 34,726 33,921 32,136 29,945 26,225 25,146 26,598 26,585 27,577
Total Current Liabilities
14,121 15,059 15,282 13,486 13,098 10,491 10,359 12,018 13,395 12,811 14,721
Short-Term Debt
4,557 3,153 3,324 1,407 524 850 909 1,632 1,123 1,051 1,894
Accounts Payable
7,727 10,016 10,036 10,223 10,663 8,442 8,382 9,121 10,904 10,375 11,490
Dividends Payable
634 702 699 701 702 184 189 263 374 403 443
Current Deferred & Payable Income Tax Liabilities
1,203 1,188 1,223 1,155 1,209 1,015 879 1,002 994 982 894
Total Noncurrent Liabilities
17,979 21,368 19,444 20,435 19,038 19,454 15,866 13,128 13,203 13,774 12,856
Long-Term Debt
14,442 16,463 14,875 14,644 14,770 16,036 13,286 10,594 10,842 11,023 9,742
Noncurrent Deferred & Payable Income Tax Liabilities
1,075 1,880 1,650 1,441 491 19 94 61 140 67 644
Noncurrent Employee Benefit Liabilities
1,434 1,495 1,082 1,153 967 1,049 231 165 175 512 479
Other Noncurrent Operating Liabilities
1,028 1,530 1,837 3,197 2,810 2,350 2,255 2,308 2,046 2,172 1,991
Total Equity & Noncontrolling Interests
35,905 41,529 37,261 36,586 24,176 12,489 15,286 17,989 21,359 22,350 27,291
Total Preferred & Common Equity
35,633 41,078 36,842 36,162 23,760 12,071 15,004 17,685 20,189 21,130 26,109
Total Common Equity
35,633 41,078 36,842 36,162 23,760 12,071 15,004 17,685 20,189 21,130 26,109
Common Stock
12,693 12,801 12,975 13,132 13,078 12,970 12,608 11,837 11,624 11,458 16,354
Retained Earnings
40,870 36,470 32,190 31,658 18,751 7,018 8,199 10,719 13,497 16,395 18,067
Treasury Stock
-13,372 -3,550 -4,049 -4,006 -3,631 -3,033 -2,233 -1,016 -678 -1,773 -3,576
Accumulated Other Comprehensive Income / (Loss)
-4,558 -4,643 -4,274 -4,622 -4,438 -4,884 -3,570 -3,855 -4,254 -4,950 -4,736
Noncontrolling Interest
272 451 419 424 416 418 282 304 1,170 1,220 1,182

Quarterly Balance Sheets for SLB

This table presents SLB's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
44,826 45,813 47,957 47,856 49,373 49,775 48,935 49,002 48,769 55,093 54,526
Total Current Assets
16,154 17,038 17,718 17,700 18,517 18,801 18,570 18,595 18,453 19,468 19,335
Cash & Equivalents
1,930 2,488 2,900 2,788 2,953 3,086 3,544 2,936 3,236 3,014 2,819
Short-Term Investments
1,264 1,247 1,089 703 1,050 1,376 1,125 961 511 571 568
Accounts Receivable
7,675 8,049 7,812 8,222 8,605 8,260 8,011 8,604 8,586 9,101 9,037
Inventories, net
4,360 4,305 4,387 4,549 4,504 4,573 4,375 4,650 4,740 5,321 5,274
Other Current Assets
925 949 1,530 1,438 1,405 1,506 1,515 1,444 1,380 1,461 1,637
Plant, Property, & Equipment, net
6,804 6,875 7,240 7,253 7,335 7,360 7,359 7,399 7,399 7,999 7,747
Total Noncurrent Assets
21,868 21,900 22,999 22,903 23,521 23,614 23,006 23,008 22,917 27,626 27,444
Long-Term Investments
1,601 1,622 1,624 1,606 1,678 1,744 1,635 1,641 1,676 1,691 1,784
Goodwill
13,117 13,111 14,084 14,086 14,530 14,559 14,593 14,637 14,658 17,007 16,852
Intangible Assets
2,968 2,912 3,239 3,167 3,198 3,122 3,012 2,963 2,893 5,089 4,901
Other Noncurrent Operating Assets
4,182 4,255 4,052 4,044 4,115 4,189 3,766 3,767 3,690 3,839 3,907
Total Liabilities & Shareholders' Equity
44,826 45,813 47,957 47,856 49,373 49,775 48,935 49,002 48,769 55,093 54,526
Total Liabilities
25,892 26,106 26,598 25,933 27,093 27,047 26,585 28,254 27,218 28,171 27,173
Total Current Liabilities
12,163 12,528 13,395 12,879 12,409 12,699 12,811 15,036 14,035 14,037 14,413
Short-Term Debt
1,993 1,998 1,123 1,430 1,033 1,059 1,051 3,475 2,807 1,923 1,938
Accounts Payable
8,938 9,222 10,904 10,051 10,099 10,346 10,375 10,221 9,993 10,857 11,140
Dividends Payable
373 373 374 411 410 406 403 404 402 443 457
Current Deferred & Payable Income Tax Liabilities
859 935 994 987 867 888 982 936 833 814 878
Total Noncurrent Liabilities
13,729 13,578 13,203 13,054 14,684 14,348 13,774 13,218 13,183 14,134 12,760
Long-Term Debt
11,342 11,147 10,842 10,740 12,156 11,864 11,023 10,527 10,891 10,843 9,670
Noncurrent Deferred & Payable Income Tax Liabilities
183 157 140 115 135 171 67 37 12 827 704
Noncurrent Employee Benefit Liabilities
167 166 175 177 175 176 512 507 502 502 474
Other Noncurrent Operating Liabilities
2,037 2,108 2,046 2,022 2,218 2,137 2,172 2,147 1,778 1,962 1,912
Total Equity & Noncontrolling Interests
18,934 19,707 21,359 21,923 22,280 22,728 22,350 20,748 21,551 26,922 27,353
Total Preferred & Common Equity
18,608 19,386 20,189 20,736 21,071 21,511 21,130 19,515 20,302 25,635 26,177
Total Common Equity
18,608 19,386 20,189 20,736 21,071 21,511 21,130 19,515 20,302 25,635 26,177
Common Stock
11,270 11,182 11,624 11,344 11,401 11,408 11,458 10,827 11,354 16,338 16,198
Retained Earnings
11,974 12,742 13,497 14,172 14,890 15,687 16,395 16,804 17,433 17,746 18,369
Treasury Stock
-750 -621 -678 -531 -973 -1,294 -1,773 -3,292 -3,742 -3,636 -3,650
Accumulated Other Comprehensive Income / (Loss)
-3,886 -3,917 -4,254 -4,249 -4,247 -4,290 -4,950 -4,824 -4,743 -4,813 -4,740
Noncontrolling Interest
326 321 1,170 1,187 1,209 1,217 1,220 1,233 1,249 1,287 1,176

Annual Metrics And Ratios for SLB

This table displays calculated financial ratios and metrics derived from SLB's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-26.98% -21.61% 9.46% 7.80% 0.31% -28.30% -2.85% 22.51% 17.96% 9.52% -1.60%
EBITDA Growth
-40.15% -63.80% 17.08% 120.49% -195.46% -33.78% 157.91% 28.93% 23.13% 7.32% -13.77%
EBIT Growth
-61.24% -151.32% 45.21% 462.66% -424.43% -11.19% 125.13% 50.13% 31.13% 6.63% -24.74%
NOPAT Growth
-61.58% -148.48% 254.40% 41.78% -401.84% -8.48% 129.16% 51.14% 29.80% 6.36% -25.03%
Net Income Growth
-61.22% -176.21% 7.01% 243.89% -564.26% -3.75% 118.39% 81.12% 22.42% 7.11% -24.63%
EPS Growth
-60.82% -176.07% 12.90% 241.67% -578.43% -3.42% 117.44% 81.06% 21.76% 6.87% -24.44%
Operating Cash Flow Growth
-23.59% -26.96% -9.55% 0.88% -4.94% -45.79% 57.98% -20.02% 78.41% -0.53% -1.71%
Free Cash Flow Firm Growth
-33.18% -422.28% 123.99% -10.47% 90.40% -22.56% -47.00% -16.56% 23.72% 82.82% -131.53%
Invested Capital Growth
-4.77% 31.81% -3.05% -1.07% -25.67% -32.79% -0.02% 6.19% 8.01% 1.56% 17.01%
Revenue Q/Q Growth
-12.13% -2.24% 3.65% 0.00% 0.15% -10.25% 3.12% 6.26% 3.47% 0.82% 1.31%
EBITDA Q/Q Growth
-21.37% 66.49% -41.31% -4.63% -0.67% -1.75% 7.48% 8.18% 3.11% -0.31% -2.13%
EBIT Q/Q Growth
-37.82% 38.70% -172.63% -9.87% 0.29% 1.08% 16.47% 12.43% 3.30% -1.11% -8.50%
NOPAT Q/Q Growth
-37.12% 38.70% 106.66% -0.71% -2.20% 1.08% 16.34% 11.98% 3.19% -0.95% -7.56%
Net Income Q/Q Growth
-37.99% 32.85% -367.79% 438.57% -2.08% 0.39% 13.41% 15.63% 1.54% -0.65% -8.44%
EPS Q/Q Growth
-38.95% 31.87% -427.27% 425.53% -1.81% 0.39% 11.86% 14.90% 1.04% 0.32% -9.27%
Operating Cash Flow Q/Q Growth
-16.83% -2.57% 4.39% 1.42% -1.43% -31.82% 29.30% -7.88% 26.93% -8.74% 10.47%
Free Cash Flow Firm Q/Q Growth
-37.85% -1.19% 110.84% -8.10% -2.97% -19.04% -18.96% 27.52% 7.80% 54.59% -11.22%
Invested Capital Q/Q Growth
-4.64% -2.02% -3.67% -3.25% -4.29% -2.20% 1.20% 0.97% 0.78% -4.45% -4.25%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.17% 12.23% 12.80% 13.22% 12.75% 11.02% 15.95% 18.37% 19.81% 20.56% 18.22%
EBITDA Margin
19.93% 9.20% 9.84% 20.13% -19.16% -35.74% 21.30% 22.42% 23.40% 22.94% 20.10%
Operating Margin
8.43% -5.52% 7.79% 8.64% -30.81% -46.62% 12.06% 14.78% 16.43% 15.99% 12.23%
EBIT Margin
8.43% -5.52% -2.76% 9.29% -30.06% -46.62% 12.06% 14.78% 16.43% 15.99% 12.23%
Profit (Net Income) Margin
6.02% -5.85% -4.97% 6.63% -30.70% -44.43% 8.41% 12.43% 12.90% 12.62% 9.66%
Tax Burden Percent
74.11% 85.41% 127.90% 82.96% 97.01% 92.81% 81.21% 81.76% 80.94% 80.73% 80.42%
Interest Burden Percent
96.32% 124.10% 140.67% 86.03% 105.29% 102.69% 85.86% 102.89% 97.04% 97.73% 98.24%
Effective Tax Rate
25.89% 0.00% 0.00% 17.04% 0.00% 0.00% 18.79% 18.24% 19.06% 19.27% 19.58%
Return on Invested Capital (ROIC)
5.58% -2.39% 3.30% 4.77% -16.61% -25.28% 9.17% 13.44% 16.29% 16.55% 11.35%
ROIC Less NNEP Spread (ROIC-NNEP)
2.63% -11.27% -25.71% 3.36% -40.97% -48.23% 6.17% 14.58% 14.52% 14.90% 10.34%
Return on Net Nonoperating Assets (RNNOA)
0.20% -1.81% -7.14% 1.12% -16.65% -31.92% 4.71% 7.54% 5.44% 4.40% 2.55%
Return on Equity (ROE)
5.77% -4.20% -3.84% 5.90% -33.27% -57.20% 13.88% 20.99% 21.73% 20.95% 13.90%
Cash Return on Invested Capital (CROIC)
10.47% -29.84% 6.39% 5.84% 12.83% 13.94% 9.19% 7.44% 8.59% 15.01% -4.33%
Operating Return on Assets (OROA)
4.43% -2.10% -1.12% 4.28% -15.60% -22.28% 6.59% 9.81% 11.95% 11.98% 8.42%
Return on Assets (ROA)
3.17% -2.23% -2.02% 3.06% -15.94% -21.24% 4.59% 8.25% 9.39% 9.45% 6.65%
Return on Common Equity (ROCE)
5.74% -4.16% -3.80% 5.83% -32.81% -55.90% 13.53% 20.62% 20.92% 19.81% 13.23%
Return on Equity Simple (ROE_SIMPLE)
5.99% -3.96% -4.11% 6.02% -42.54% -86.87% 12.85% 19.75% 21.17% 21.67% 0.00%
Net Operating Profit after Tax (NOPAT)
2,217 -1,075 1,659 2,352 -7,099 -7,701 2,246 3,394 4,405 4,686 3,513
NOPAT Margin
6.25% -3.86% 5.45% 7.17% -21.57% -32.63% 9.79% 12.08% 13.30% 12.91% 9.84%
Net Nonoperating Expense Percent (NNEP)
2.94% 8.88% 29.01% 1.42% 24.35% 22.95% 3.00% -1.14% 1.77% 1.65% 1.01%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 11.23% 13.22% 13.61% 9.02%
Cost of Revenue to Revenue
79.83% 87.77% 87.20% 86.78% 87.25% 88.98% 84.05% 81.63% 80.19% 79.44% 81.78%
SG&A Expenses to Revenue
1.39% 1.45% 1.42% 1.35% 1.44% 1.55% 1.48% 1.34% 1.10% 1.06% 0.95%
R&D to Revenue
3.08% 3.64% 2.59% 2.14% 2.18% 2.46% 2.42% 2.26% 2.15% 2.06% 1.99%
Operating Expenses to Revenue
11.74% 17.75% 5.02% 4.58% 43.56% 57.64% 3.89% 3.60% 3.38% 4.56% 5.99%
Earnings before Interest and Taxes (EBIT)
2,991 -1,535 -841 3,050 -9,895 -11,002 2,765 4,151 5,443 5,804 4,368
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
7,069 2,559 2,996 6,606 -6,306 -8,436 4,885 6,298 7,755 8,323 7,177
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.92 2.27 2.09 1.18 2.11 2.35 2.67 4.10 3.58 2.56 2.20
Price to Tangible Book Value (P/TBV)
4.42 14.93 32.56 17.05 79.87 0.00 0.00 42.40 25.21 15.36 13.25
Price to Revenue (P/Rev)
1.92 3.35 2.53 1.30 1.53 1.20 1.75 2.58 2.18 1.49 1.61
Price to Earnings (P/E)
32.95 0.00 0.00 19.96 0.00 0.00 21.33 21.08 17.19 12.14 16.99
Dividend Yield
3.69% 2.99% 4.49% 6.49% 5.51% 4.29% 2.18% 1.27% 1.97% 2.87% 2.97%
Earnings Yield
3.03% 0.00% 0.00% 5.01% 0.00% 0.00% 4.69% 4.74% 5.82% 8.24% 5.88%
Enterprise Value to Invested Capital (EV/IC)
1.83 2.00 1.80 1.12 1.71 1.66 2.02 3.10 2.84 2.14 1.92
Enterprise Value to Revenue (EV/Rev)
2.00 3.68 2.93 1.67 1.89 1.72 2.16 2.87 2.41 1.68 1.80
Enterprise Value to EBITDA (EV/EBITDA)
10.01 40.00 29.76 8.30 0.00 0.00 10.12 12.80 10.29 7.34 8.94
Enterprise Value to EBIT (EV/EBIT)
23.66 0.00 0.00 17.98 0.00 0.00 17.87 19.42 14.66 10.53 14.69
Enterprise Value to NOPAT (EV/NOPAT)
31.93 0.00 53.75 23.32 0.00 0.00 22.01 23.75 18.11 13.05 18.26
Enterprise Value to Operating Cash Flow (EV/OCF)
8.26 16.35 15.75 9.60 11.46 13.80 10.63 21.67 12.02 9.26 9.89
Enterprise Value to Free Cash Flow (EV/FCFF)
17.01 0.00 27.72 19.04 11.35 9.57 21.96 42.92 34.34 14.39 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.53 0.47 0.49 0.44 0.63 1.35 0.93 0.68 0.56 0.54 0.43
Long-Term Debt to Equity
0.40 0.40 0.40 0.40 0.61 1.28 0.87 0.59 0.51 0.49 0.36
Financial Leverage
0.07 0.16 0.28 0.33 0.41 0.66 0.76 0.52 0.37 0.30 0.25
Leverage Ratio
1.82 1.89 1.90 1.93 2.09 2.69 3.02 2.54 2.32 2.22 2.09
Compound Leverage Factor
1.76 2.34 2.68 1.66 2.20 2.77 2.59 2.62 2.25 2.17 2.05
Debt to Total Capital
34.60% 32.08% 32.81% 30.49% 38.75% 57.48% 48.15% 40.46% 35.91% 35.07% 29.89%
Short-Term Debt to Total Capital
8.30% 5.16% 5.99% 2.67% 1.33% 2.89% 3.08% 5.40% 3.37% 3.05% 4.87%
Long-Term Debt to Total Capital
26.30% 26.92% 26.82% 27.82% 37.42% 54.59% 45.07% 35.06% 32.54% 32.02% 25.03%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.50% 0.74% 0.76% 0.81% 1.05% 1.42% 0.96% 1.01% 3.51% 3.54% 3.04%
Common Equity to Total Capital
64.90% 67.18% 66.43% 68.70% 60.20% 41.09% 50.89% 58.53% 60.58% 61.38% 67.07%
Debt to EBITDA
2.69 7.67 6.07 2.43 -2.43 -2.00 2.91 1.94 1.54 1.45 1.62
Net Debt to EBITDA
0.32 3.47 3.87 1.78 -1.83 -1.40 1.84 1.23 0.82 0.69 0.79
Long-Term Debt to EBITDA
2.04 6.43 4.97 2.22 -2.34 -1.90 2.72 1.68 1.40 1.32 1.36
Debt to NOPAT
8.57 -18.26 10.97 6.82 -2.15 -2.19 6.32 3.60 2.72 2.58 3.31
Net Debt to NOPAT
1.01 -8.26 6.99 4.99 -1.63 -1.53 4.01 2.28 1.44 1.23 1.61
Long-Term Debt to NOPAT
6.52 -15.32 8.97 6.23 -2.08 -2.08 5.92 3.12 2.46 2.35 2.77
Altman Z-Score
3.01 2.62 2.40 2.03 1.46 0.57 2.03 3.13 3.20 2.97 2.73
Noncontrolling Interest Sharing Ratio
0.64% 0.93% 1.10% 1.14% 1.38% 2.27% 2.52% 1.76% 3.75% 5.47% 4.84%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.91 1.59 1.21 1.17 1.19 1.23 1.22 1.25 1.32 1.45 1.33
Quick Ratio
1.54 1.24 0.86 0.79 0.76 0.79 0.82 0.80 0.88 0.99 0.88
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
4,161 -13,409 3,217 2,880 5,484 4,247 2,251 1,878 2,323 4,248 -1,339
Operating Cash Flow to CapEx
295.99% 233.18% 237.64% 252.79% 277.80% 241.91% 394.15% 168.71% 271.34% 273.49% 383.06%
Free Cash Flow to Firm to Interest Expense
12.02 -23.52 5.68 5.01 9.00 7.54 4.18 3.83 4.62 8.30 -2.40
Operating Cash Flow to Interest Expense
24.77 10.98 10.01 9.94 8.92 5.23 8.63 7.59 13.19 12.89 11.63
Operating Cash Flow Less CapEx to Interest Expense
16.40 6.27 5.80 6.01 5.71 3.07 6.44 3.09 8.33 8.18 8.59
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.53 0.38 0.41 0.46 0.52 0.48 0.55 0.66 0.73 0.75 0.69
Accounts Receivable Turnover
3.56 3.06 3.48 4.11 4.21 3.63 4.34 4.65 4.55 4.59 4.28
Inventory Turnover
6.76 6.12 6.42 7.07 7.06 5.61 5.82 6.31 6.34 6.58 6.21
Fixed Asset Turnover
2.46 2.12 2.50 2.82 3.14 2.93 3.46 4.31 4.79 4.97 4.68
Accounts Payable Turnover
3.34 2.75 2.65 2.81 2.75 2.20 2.29 2.62 2.65 2.71 2.67
Days Sales Outstanding (DSO)
102.64 119.22 104.75 88.79 86.65 100.48 84.07 78.49 80.29 79.58 85.35
Days Inventory Outstanding (DIO)
54.03 59.67 56.87 51.63 51.73 65.04 62.75 57.87 57.60 55.47 58.79
Days Payable Outstanding (DPO)
109.37 132.66 137.87 129.83 132.72 166.03 159.33 139.31 137.53 134.71 136.65
Cash Conversion Cycle (CCC)
47.29 46.23 23.74 10.59 5.65 -0.51 -12.51 -2.95 0.35 0.34 7.49
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
38,775 51,109 49,551 49,023 36,440 24,492 24,487 26,003 28,085 28,523 33,375
Invested Capital Turnover
0.89 0.62 0.60 0.67 0.77 0.77 0.94 1.11 1.23 1.28 1.15
Increase / (Decrease) in Invested Capital
-1,944 12,334 -1,558 -528 -12,583 -11,948 -5.00 1,516 2,082 438 4,852
Enterprise Value (EV)
70,780 102,371 89,166 54,845 62,215 40,620 49,417 80,597 79,777 61,132 64,160
Market Capitalization
68,272 93,042 77,156 42,685 50,237 28,383 40,123 72,542 72,255 54,142 57,337
Book Value per Share
$28.26 $29.52 $26.60 $26.11 $17.16 $8.67 $10.70 $12.47 $14.18 $14.96 $17.48
Tangible Book Value per Share
$12.26 $4.48 $1.71 $1.81 $0.45 ($3.14) ($0.85) $1.21 $2.01 $2.50 $2.90
Total Capital
54,904 61,145 55,460 52,637 39,470 29,375 29,481 30,215 33,324 34,424 38,927
Total Debt
18,999 19,616 18,199 16,051 15,294 16,886 14,195 12,226 11,965 12,074 11,636
Total Long-Term Debt
14,442 16,463 14,875 14,644 14,770 16,036 13,286 10,594 10,842 11,023 9,742
Net Debt
2,236 8,878 11,591 11,736 11,562 11,819 9,012 7,751 6,352 5,770 5,641
Capital Expenditures (CapEx)
2,896 2,685 2,383 2,260 1,955 1,217 1,180 2,205 2,446 2,414 1,694
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4,314 2,764 1,450 875 789 272 65 1,723 1,457 2,141 2,474
Debt-free Net Working Capital (DFNWC)
17,348 12,021 6,539 3,652 2,956 3,278 3,204 4,617 5,446 6,810 6,686
Net Working Capital (NWC)
12,791 8,868 3,215 2,245 2,432 2,428 2,295 2,985 4,323 5,759 4,792
Net Nonoperating Expense (NNE)
82 553 3,172 175 3,008 2,785 318 -98 130 107 62
Net Nonoperating Obligations (NNO)
2,870 9,580 12,290 12,437 12,264 12,003 9,201 8,014 6,726 6,173 6,084
Total Depreciation and Amortization (D&A)
4,078 4,094 3,837 3,556 3,589 2,566 2,120 2,147 2,312 2,519 2,809
Debt-free, Cash-free Net Working Capital to Revenue
12.16% 9.94% 4.76% 2.67% 2.40% 1.15% 0.28% 6.13% 4.40% 5.90% 6.93%
Debt-free Net Working Capital to Revenue
48.90% 43.23% 21.48% 11.13% 8.98% 13.89% 13.97% 16.44% 16.44% 18.77% 18.72%
Net Working Capital to Revenue
36.06% 31.89% 10.56% 6.84% 7.39% 10.29% 10.01% 10.63% 13.05% 15.87% 13.42%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.63 ($1.24) ($1.08) $1.54 ($7.32) ($7.57) $1.34 $2.43 $2.95 $3.14 $2.38
Adjusted Weighted Average Basic Shares Outstanding
1.27B 1.36B 1.39B 1.39B 1.39B 1.39B 1.40B 1.42B 1.43B 1.42B 1.42B
Adjusted Diluted Earnings per Share
$1.63 ($1.24) ($1.08) $1.53 ($7.32) ($7.57) $1.32 $2.39 $2.91 $3.11 $2.35
Adjusted Weighted Average Diluted Shares Outstanding
1.28B 1.36B 1.39B 1.39B 1.39B 1.39B 1.43B 1.44B 1.44B 1.44B 1.44B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 ($7.32) $0.00 $1.34 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.26B 1.39B 1.38B 1.38B 1.38B 1.39B 1.40B 1.42B 1.43B 1.40B 1.50B
Normalized Net Operating Profit after Tax (NOPAT)
4,125 1,390 1,875 2,647 2,104 1,159 2,246 3,394 4,442 5,107 4,390
Normalized NOPAT Margin
11.63% 5.00% 6.16% 8.07% 6.39% 4.91% 9.79% 12.08% 13.40% 14.07% 12.29%
Pre Tax Income Margin
8.12% -6.85% -3.89% 8.00% -31.65% -47.87% 10.35% 15.20% 15.94% 15.63% 12.02%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
8.64 -2.69 -1.49 5.30 -16.25 -19.54 5.13 8.47 10.82 11.34 7.83
NOPAT to Interest Expense
6.41 -1.89 2.93 4.09 -11.66 -13.68 4.17 6.93 8.76 9.15 6.30
EBIT Less CapEx to Interest Expense
0.27 -7.40 -5.70 1.37 -19.46 -21.70 2.94 3.97 5.96 6.62 4.79
NOPAT Less CapEx to Interest Expense
-1.96 -6.60 -1.28 0.16 -14.87 -15.84 1.98 2.43 3.90 4.44 3.26
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
113.30% -162.69% -183.61% 127.24% -27.40% -16.54% 36.26% 24.28% 30.81% 33.48% 46.42%
Augmented Payout Ratio
215.50% -210.51% -247.65% 145.61% -30.15% -16.78% 36.26% 24.28% 47.04% 71.41% 116.37%

Quarterly Metrics And Ratios for SLB

This table displays calculated financial ratios and metrics derived from SLB's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 1,495,057,661.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,495,057,661.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.50
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.14% 14.10% 12.55% 12.84% 10.22% 3.27% -2.49% -6.49% -2.52% 4.95% 2.72%
EBITDA Growth
18.44% 12.70% 13.55% 10.53% 7.73% -1.25% -10.78% -13.86% -22.18% -15.70% -3.27%
EBIT Growth
22.86% 13.45% 16.86% 9.72% 6.62% -4.43% -18.33% -19.96% -31.22% -28.94% -9.10%
NOPAT Growth
23.46% 13.04% 16.30% 9.18% 5.82% -3.84% -21.28% -18.99% -34.13% -25.21% -7.22%
Net Income Growth
23.61% 6.00% 16.31% 9.36% 7.22% -2.61% -24.50% -8.47% -36.45% -28.44% -8.20%
EPS Growth
23.81% 4.11% 13.85% 6.94% 6.41% 1.32% -21.62% -3.90% -39.76% -31.17% -13.79%
Operating Cash Flow Growth
7.02% 87.24% -0.91% -10.70% 46.03% -20.91% 101.83% -20.47% -31.32% 25.73% -26.21%
Free Cash Flow Firm Growth
-55.16% -90.48% 40.05% -93.22% 21.42% 176.48% 189.66% 179.47% -470.58% -678.18% -665.72%
Invested Capital Growth
8.21% 8.01% 6.80% 8.44% 7.12% 1.56% 0.71% 0.10% 16.76% 17.01% 15.64%
Revenue Q/Q Growth
2.61% 8.18% -3.15% 4.96% 0.22% 1.36% -8.55% 0.66% 4.47% 9.14% -10.50%
EBITDA Q/Q Growth
6.90% 2.32% -4.38% 5.69% 4.19% -6.22% -13.60% 2.03% -5.86% 1.59% -0.87%
EBIT Q/Q Growth
8.45% 1.17% -5.59% 5.92% 5.38% -9.31% -19.32% 3.80% -9.45% -6.30% 3.21%
NOPAT Q/Q Growth
9.06% -0.47% -4.64% 5.48% 5.70% -9.55% -21.94% 8.55% -14.06% 2.70% -3.16%
Net Income Q/Q Growth
8.50% 1.06% -4.36% 4.28% 6.38% -8.21% -25.85% 26.42% -26.15% 3.36% -4.88%
EPS Q/Q Growth
8.33% -2.56% -2.63% 4.05% 7.79% -7.23% -24.68% 27.59% -32.43% 6.00% -5.66%
Operating Cash Flow Q/Q Growth
4.29% 80.20% -89.18% 339.14% 70.54% -2.41% -72.38% 73.03% 47.29% 78.66% -83.79%
Free Cash Flow Firm Q/Q Growth
-54.23% 2.84% 17.05% -55.43% 37.28% 194.57% -2.75% 37.77% -550.34% 4.17% 4.85%
Invested Capital Q/Q Growth
0.08% 0.78% 4.71% 2.69% -1.15% -4.45% 3.83% 2.07% 15.31% -4.25% 2.61%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.67% 19.99% 19.52% 20.54% 20.98% 21.12% 18.92% 18.86% 17.45% 17.76% 15.26%
EBITDA Margin
24.43% 23.10% 22.81% 22.97% 23.88% 22.09% 20.87% 21.16% 19.06% 17.74% 19.65%
Operating Margin
17.46% 16.33% 15.92% 16.06% 16.89% 15.11% 13.33% 13.75% 11.92% 10.23% 11.80%
EBIT Margin
17.46% 16.33% 15.92% 16.06% 16.89% 15.11% 13.33% 13.75% 11.92% 10.23% 11.80%
Profit (Net Income) Margin
13.67% 12.77% 12.61% 12.53% 13.30% 12.04% 9.76% 12.26% 8.67% 8.21% 8.73%
Tax Burden Percent
81.43% 80.11% 80.91% 80.58% 80.82% 80.61% 77.99% 81.56% 77.40% 84.84% 79.60%
Interest Burden Percent
96.14% 97.62% 97.91% 96.80% 97.41% 98.86% 93.90% 109.36% 93.99% 94.58% 92.91%
Effective Tax Rate
18.57% 19.89% 19.09% 19.42% 19.18% 19.39% 22.01% 18.44% 22.60% 15.16% 20.40%
Return on Invested Capital (ROIC)
16.98% 16.03% 15.43% 15.67% 17.03% 15.62% 12.71% 13.17% 10.05% 10.02% 10.57%
ROIC Less NNEP Spread (ROIC-NNEP)
16.43% 15.65% 15.15% 15.22% 16.60% 15.42% 12.05% 14.25% 9.39% 9.27% 9.83%
Return on Net Nonoperating Assets (RNNOA)
7.24% 5.86% 6.25% 6.22% 5.98% 4.55% 4.62% 5.39% 2.85% 2.29% 3.22%
Return on Equity (ROE)
24.22% 21.89% 21.68% 21.89% 23.01% 20.17% 17.33% 18.56% 12.90% 12.30% 13.79%
Cash Return on Invested Capital (CROIC)
8.04% 8.59% 9.45% 7.96% 9.52% 15.01% 14.36% 13.88% -3.72% -4.33% -3.70%
Operating Return on Assets (OROA)
12.44% 11.88% 11.84% 11.99% 12.72% 11.32% 9.93% 9.94% 8.01% 7.04% 8.19%
Return on Assets (ROA)
9.74% 9.29% 9.38% 9.35% 10.02% 9.02% 7.27% 8.87% 5.83% 5.65% 6.06%
Return on Common Equity (ROCE)
23.81% 21.07% 20.88% 21.08% 22.17% 19.06% 16.35% 17.52% 12.25% 11.71% 13.10%
Return on Equity Simple (ROE_SIMPLE)
21.72% 0.00% 21.36% 21.48% 21.43% 0.00% 22.09% 20.75% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,182 1,176 1,121 1,183 1,250 1,131 883 958 824 846 819
NOPAT Margin
14.22% 13.08% 12.88% 12.94% 13.65% 12.18% 10.40% 11.21% 9.22% 8.68% 9.39%
Net Nonoperating Expense Percent (NNEP)
0.56% 0.38% 0.28% 0.45% 0.42% 0.20% 0.66% -1.08% 0.66% 0.75% 0.74%
Return On Investment Capital (ROIC_SIMPLE)
- 3.53% - - - 3.29% 2.54% 2.72% 2.08% 2.17% 2.10%
Cost of Revenue to Revenue
79.33% 80.01% 80.48% 79.46% 79.02% 78.88% 81.08% 81.14% 82.55% 82.24% 84.74%
SG&A Expenses to Revenue
0.97% 1.07% 1.39% 1.03% 0.98% 0.86% 1.13% 1.02% 0.81% 0.87% 1.11%
R&D to Revenue
2.24% 2.09% 2.09% 2.06% 2.04% 2.07% 2.03% 2.11% 1.90% 1.92% 1.88%
Operating Expenses to Revenue
3.21% 3.66% 3.61% 4.48% 4.09% 6.01% 5.58% 5.11% 5.53% 7.53% 3.46%
Earnings before Interest and Taxes (EBIT)
1,451 1,468 1,386 1,468 1,547 1,403 1,132 1,175 1,064 997 1,029
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,030 2,077 1,986 2,099 2,187 2,051 1,772 1,808 1,702 1,729 1,714
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.18 3.58 3.75 3.20 2.77 2.56 3.00 2.26 1.81 2.20 2.94
Price to Tangible Book Value (P/TBV)
24.07 25.21 22.32 20.17 15.55 15.36 30.58 16.71 13.12 13.25 17.37
Price to Revenue (P/Rev)
2.53 2.18 2.28 1.92 1.65 1.49 1.62 1.30 1.32 1.61 2.14
Price to Earnings (P/E)
19.48 17.19 17.92 15.27 13.30 12.14 13.98 11.24 12.74 16.99 23.08
Dividend Yield
1.62% 1.97% 1.88% 2.23% 2.56% 2.87% 2.66% 3.31% 3.29% 2.97% 2.24%
Earnings Yield
5.13% 5.82% 5.58% 6.55% 7.52% 8.24% 7.16% 8.90% 7.85% 5.88% 4.33%
Enterprise Value to Invested Capital (EV/IC)
3.20 2.84 2.92 2.52 2.26 2.14 2.30 1.84 1.58 1.92 2.47
Enterprise Value to Revenue (EV/Rev)
2.78 2.41 2.52 2.17 1.88 1.68 1.89 1.56 1.57 1.80 2.35
Enterprise Value to EBITDA (EV/EBITDA)
11.84 10.29 10.76 9.30 8.08 7.34 8.42 7.10 7.53 8.94 12.15
Enterprise Value to EBIT (EV/EBIT)
16.90 14.66 15.24 13.19 11.50 10.53 12.30 10.56 11.57 14.69 19.80
Enterprise Value to NOPAT (EV/NOPAT)
20.86 18.11 18.85 16.34 14.27 13.05 15.35 13.14 14.53 18.26 24.49
Enterprise Value to Operating Cash Flow (EV/OCF)
17.03 12.02 12.96 11.78 9.33 9.26 9.84 8.36 9.40 9.89 13.37
Enterprise Value to Free Cash Flow (EV/FCFF)
41.32 34.34 31.98 32.95 24.56 14.39 16.10 13.23 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.67 0.56 0.56 0.59 0.57 0.54 0.67 0.64 0.47 0.43 0.42
Long-Term Debt to Equity
0.57 0.51 0.49 0.55 0.52 0.49 0.51 0.51 0.40 0.36 0.35
Financial Leverage
0.44 0.37 0.41 0.41 0.36 0.30 0.38 0.38 0.30 0.25 0.33
Leverage Ratio
2.42 2.32 2.28 2.29 2.25 2.22 2.27 2.24 2.11 2.09 2.15
Compound Leverage Factor
2.32 2.26 2.23 2.21 2.19 2.19 2.13 2.45 1.99 1.98 2.00
Debt to Total Capital
40.01% 35.91% 35.70% 37.18% 36.25% 35.07% 40.29% 38.86% 32.17% 29.89% 29.79%
Short-Term Debt to Total Capital
6.08% 3.37% 4.19% 2.91% 2.97% 3.05% 10.00% 7.96% 4.85% 4.87% 4.97%
Long-Term Debt to Total Capital
33.93% 32.54% 31.50% 34.27% 33.28% 32.02% 30.29% 30.90% 27.32% 25.03% 24.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.98% 3.51% 3.48% 3.41% 3.41% 3.54% 3.55% 3.54% 3.24% 3.04% 3.02%
Common Equity to Total Capital
59.01% 60.58% 60.82% 59.41% 60.34% 61.38% 56.16% 57.60% 64.59% 67.07% 67.19%
Debt to EBITDA
1.75 1.54 1.52 1.61 1.55 1.45 1.73 1.75 1.74 1.62 1.67
Net Debt to EBITDA
1.04 0.82 0.89 0.92 0.80 0.69 1.04 1.06 1.02 0.79 0.93
Long-Term Debt to EBITDA
1.48 1.40 1.34 1.48 1.42 1.32 1.30 1.39 1.48 1.36 1.39
Debt to NOPAT
3.08 2.72 2.67 2.83 2.73 2.58 3.15 3.24 3.36 3.31 3.37
Net Debt to NOPAT
1.82 1.44 1.55 1.61 1.42 1.23 1.90 1.96 1.97 1.61 1.87
Long-Term Debt to NOPAT
2.61 2.46 2.35 2.61 2.51 2.35 2.37 2.58 2.85 2.77 2.80
Altman Z-Score
3.17 2.92 3.14 2.87 2.74 2.67 2.62 2.43 2.26 2.52 3.00
Noncontrolling Interest Sharing Ratio
1.70% 3.75% 3.72% 3.72% 3.62% 5.47% 5.67% 5.61% 5.04% 4.84% 5.01%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.36 1.32 1.37 1.49 1.48 1.45 1.24 1.31 1.39 1.33 1.34
Quick Ratio
0.94 0.88 0.91 1.02 1.00 0.99 0.83 0.88 0.90 0.88 0.86
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-932 -906 -752 -1,168 -733 693 674 928 -4,180 -4,006 -3,812
Operating Cash Flow to CapEx
334.06% 308.37% 76.40% 273.52% 480.20% 251.31% 165.83% 307.82% 411.25% 582.36% 141.98%
Free Cash Flow to Firm to Interest Expense
-7.23 -6.97 -6.65 -8.85 -5.39 5.29 4.58 6.54 -29.44 -31.54 -32.86
Operating Cash Flow to Interest Expense
13.00 23.25 2.89 10.88 18.01 18.24 4.49 8.04 11.85 23.66 4.20
Operating Cash Flow Less CapEx to Interest Expense
9.11 15.71 -0.89 6.90 14.26 10.98 1.78 5.43 8.96 19.60 1.24
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.71 0.73 0.74 0.75 0.75 0.75 0.74 0.72 0.67 0.69 0.69
Accounts Receivable Turnover
4.36 4.55 4.32 4.32 4.41 4.59 4.29 4.13 4.06 4.28 4.07
Inventory Turnover
6.08 6.34 6.18 6.33 6.47 6.58 6.24 6.14 5.76 6.21 5.99
Fixed Asset Turnover
4.82 4.79 4.89 4.97 5.06 4.97 4.92 4.82 4.59 4.68 4.75
Accounts Payable Turnover
2.81 2.65 2.91 2.95 2.93 2.71 2.83 2.82 2.69 2.67 2.78
Days Sales Outstanding (DSO)
83.77 80.29 84.55 84.54 82.69 79.58 85.13 88.43 89.89 85.35 89.58
Days Inventory Outstanding (DIO)
60.02 57.60 59.07 57.66 56.46 55.47 58.48 59.45 63.33 58.79 60.97
Days Payable Outstanding (DPO)
129.71 137.53 125.38 123.84 124.44 134.71 128.88 129.21 135.72 136.65 131.23
Cash Conversion Cycle (CCC)
14.08 0.35 18.24 18.36 14.71 0.34 14.73 18.66 17.50 7.49 19.32
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
27,868 28,085 29,407 30,198 29,851 28,523 29,616 30,228 34,855 33,375 34,247
Invested Capital Turnover
1.19 1.23 1.20 1.21 1.25 1.28 1.22 1.17 1.09 1.15 1.13
Increase / (Decrease) in Invested Capital
2,114 2,082 1,873 2,351 1,983 438 209 30 5,004 4,852 4,631
Enterprise Value (EV)
89,050 79,777 86,000 76,153 67,496 61,132 68,253 55,497 55,219 64,160 84,458
Market Capitalization
80,941 72,255 77,740 67,436 59,562 54,142 58,556 45,973 46,442 57,337 76,845
Book Value per Share
$13.64 $14.18 $14.53 $14.74 $15.15 $14.96 $13.93 $14.93 $18.97 $17.48 $17.51
Tangible Book Value per Share
$2.37 $2.01 $2.44 $2.34 $2.70 $2.50 $1.37 $2.02 $2.62 $2.90 $2.96
Total Capital
32,852 33,324 34,093 35,469 35,651 34,424 34,750 35,249 39,688 38,927 38,961
Total Debt
13,145 11,965 12,170 13,189 12,923 12,074 14,002 13,698 12,766 11,636 11,608
Total Long-Term Debt
11,147 10,842 10,740 12,156 11,864 11,023 10,527 10,891 10,843 9,742 9,670
Net Debt
7,788 6,352 7,073 7,508 6,717 5,770 8,464 8,275 7,490 5,641 6,437
Capital Expenditures (CapEx)
502 980 428 525 510 951 398 371 409 516 343
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,773 1,457 2,760 3,138 2,699 2,141 3,137 3,478 3,769 2,474 3,473
Debt-free Net Working Capital (DFNWC)
6,508 5,446 6,251 7,141 7,161 6,810 7,034 7,225 7,354 6,686 6,860
Net Working Capital (NWC)
4,510 4,323 4,821 6,108 6,102 5,759 3,559 4,418 5,431 4,792 4,922
Net Nonoperating Expense (NNE)
46 28 23 38 32 13 54 -90 50 46 58
Net Nonoperating Obligations (NNO)
8,161 6,726 7,484 7,918 7,123 6,173 8,868 8,677 7,933 6,084 6,894
Total Depreciation and Amortization (D&A)
579 609 600 631 640 648 640 633 638 732 685
Debt-free, Cash-free Net Working Capital to Revenue
8.66% 4.40% 8.09% 8.93% 7.50% 5.90% 8.70% 9.80% 10.69% 6.93% 9.66%
Debt-free Net Working Capital to Revenue
20.32% 16.44% 18.33% 20.32% 19.89% 18.77% 19.50% 20.36% 20.86% 18.72% 19.09%
Net Working Capital to Revenue
14.08% 13.05% 14.14% 17.38% 16.95% 15.87% 9.87% 12.45% 15.41% 13.42% 13.70%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.79 $0.78 $0.75 $0.78 $0.84 $0.77 $0.58 $0.75 $0.50 $0.55 $0.50
Adjusted Weighted Average Basic Shares Outstanding
1.42B 1.43B 1.43B 1.43B 1.42B 1.42B 1.37B 1.35B 1.47B 1.42B 1.50B
Adjusted Diluted Earnings per Share
$0.78 $0.76 $0.74 $0.77 $0.83 $0.77 $0.58 $0.74 $0.50 $0.53 $0.50
Adjusted Weighted Average Diluted Shares Outstanding
1.44B 1.44B 1.45B 1.44B 1.43B 1.44B 1.38B 1.37B 1.49B 1.44B 1.52B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.75 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.42B 1.43B 1.43B 1.42B 1.41B 1.40B 1.36B 1.35B 1.49B 1.50B 1.50B
Normalized Net Operating Profit after Tax (NOPAT)
1,182 1,212 1,130 1,285 1,330 1,361 1,043 1,097 1,019 957 852
Normalized NOPAT Margin
14.22% 13.48% 12.98% 14.06% 14.52% 14.66% 12.29% 12.84% 11.41% 9.82% 9.77%
Pre Tax Income Margin
16.79% 15.94% 15.59% 15.55% 16.45% 14.94% 12.52% 15.04% 11.20% 9.68% 10.96%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
11.25 11.29 12.27 11.12 11.38 10.71 7.70 8.27 7.49 7.85 8.87
NOPAT to Interest Expense
9.16 9.05 9.92 8.96 9.19 8.63 6.01 6.75 5.80 6.66 7.06
EBIT Less CapEx to Interest Expense
7.36 3.75 8.48 7.14 7.63 3.45 4.99 5.66 4.61 3.79 5.91
NOPAT Less CapEx to Interest Expense
5.27 1.51 6.14 4.98 5.44 1.37 3.30 4.14 2.92 2.60 4.10
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
28.72% 30.81% 32.17% 32.32% 32.55% 33.48% 36.24% 36.91% 41.52% 46.42% 48.54%
Augmented Payout Ratio
42.83% 47.04% 48.75% 54.10% 61.53% 71.41% 123.64% 115.29% 118.86% 116.37% 65.24%

Financials Breakdown Chart

Key Financial Trends

Schlumberger (NYSE: SLB) has shown a pattern of solid cash generation with a steading top-line in the 2022–2025 window, alongside a modest but persistent margin compression as energy markets evolved. The company’s quarterly data indicate strong operating cash flow and meaningful free cash flow in late 2024 through 2025, with a balance sheet that remains well-capitalized and leveraged at a moderate level. The highlights below capture the most important near-term trends for retail investors.

  • Q4 2025 revenue reached 9.744 billion USD, up from 9.284 billion USD in Q4 2024, signaling a year-over-year top-line improvement after a period of relative flatness.
  • Free cash flow remains robust: Q4 2025 net cash from continuing operating activities was about 3.005 billion USD and free cash flow (approx. 3.005B minus 0.516B capex) around 2.49 billion USD, a strong indicator of discretionary cash generation.
  • Operating cash flow trended higher in late 2024 through 2025 versus the prior year, supporting ongoing capital returns and optionality for strategic investments.
  • The company maintains solid liquidity, with substantial cash flow generation contributing to a sizable liquidity cushion in quarterly results and a historically strong balance sheet position.
  • Dividend policy continues to provide shareholder value, as reflected in ongoing cash outflows for dividends and related financing activity, indicating an ongoing capital return to shareholders.
  • Gross margin softened in 2025 (roughly 18%–19%) versus 2024 (about 21%), suggesting a shift in cost structure or mix that may pressure near-term profitability if input costs persist.
  • Earnings show quarterly volatility: net income to common shareholders fluctuated (e.g., 1.014B in Q2 2025, 0.739B in Q3 2025, 0.824B in Q4 2025), indicating earnings sensitivity to revenue mix and cost control on a quarterly basis.
  • Debt levels remained at a moderate, manageable level for SLB, with long-term debt around 10.8–11.0B USD in 2025 and a balanced debt profile relative to equity, suggesting room to optimize capital structure if needed.
  • Gross margin decline combined with sustained operating expenses (S&A and R&D) in some periods points to profitability compression that could persist if commodity pricing or utilization trends remain pressured.
  • Earnings per share and per-share metrics have shown variability across quarters, reflecting revenue and margin dynamics, which may complicate near-term expectations for investors relying on stable earnings streams.
05/14/26 08:27 AM ETAI Generated. May Contain Errors.

SLB Financials - Frequently Asked Questions

According to the most recent income statement we have on file, SLB's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

SLB's net income appears to be on a downward trend, with a most recent value of $3.45 billion in 2025, rising from $2.14 billion in 2015. The previous period was $4.58 billion in 2024. Check out SLB's forecast to explore projected trends and price targets.

SLB's total operating income in 2025 was $4.37 billion, based on the following breakdown:
  • Total Gross Profit: $6.51 billion
  • Total Operating Expenses: $2.14 billion

Over the last 10 years, SLB's total revenue changed from $35.48 billion in 2015 to $35.71 billion in 2025, a change of 0.7%.

SLB's total liabilities were at $27.58 billion at the end of 2025, a 3.7% increase from 2024, and a 14.1% decrease since 2015.

In the past 10 years, SLB's cash and equivalents has ranged from $844 million in 2020 to $3.54 billion in 2024, and is currently $3.04 billion as of their latest financial filing in 2025.

Over the last 10 years, SLB's book value per share changed from 28.26 in 2015 to 17.48 in 2025, a change of -38.1%.



Financial statements for NYSE:SLB last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners